This educational activity is specifically designed for hematologists/oncologists, internists, nurses, pharmacists, and other healthcare professionals with an interest and/or involvement in hematologic malignancies.
Objectives After successful completion of this course, attendees should be able to:
- Discuss the most clinically relevant data presented at the 51st Annual Hematology Meeting
- Analyze emerging data on multiple hematologic malignancies and benign abnormalities in order to improve patient outcomes
- Explain the limitations and benefits of new and emerging therapies for the treatment of patients with benign and malignant hematologic conditions
- Incorporate emerging data into the clinical management of patients with benign and malignant hematologic conditions
- Discuss ways in which current clinical practice should be modified based on the latest advances in hematology
